LANCLCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPRダブルニッカーゼプラスミドを含め、広範囲の遺伝子編集製品を提供しております。LANCL遺伝子サイレンサーは、LANCL CRISPR/Cas9ノックアウトプラスミドとLANCLダブルニッカーゼプラスミドとして利用可能です。遺伝子活性化用のLANCLCRISPR/dCas9アクティベーションプラスミド及びCRISPRレンチアクティベーションシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用する抗体と組み合わせた遺伝子研究に有用です。
LANCL CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
LANCL1 CRISPR/Cas9 KOプラスミド (h) | sc-409776 | h | Gene Knockout | GFP | 0 | ||
LANCL1 HDRプラスミド (h) | sc-409776-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
LANCL1 Double Nickaseプラスミド (h) | sc-409776-NIC | h | Gene Knockout | Puromycin | 0 | ||
LANCL1 Double Nickaseプラスミド (h2) | sc-409776-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
LANCL1 CRISPR/Cas9 KOプラスミド (m) | sc-420659 | m | Gene Knockout | GFP | 0 | ||
LANCL1 HDRプラスミド (m) | sc-420659-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
LANCL1 Double Nickaseプラスミド (m) | sc-420659-NIC | m | Gene Knockout | Puromycin | 0 | ||
LANCL1 Double Nickaseプラスミド (m2) | sc-420659-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
LANCL2 CRISPR/Cas9 KOプラスミド (h) | sc-410036 | h | Gene Knockout | GFP | 0 | ||
LANCL2 HDRプラスミド (h) | sc-410036-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
LANCL2 Double Nickaseプラスミド (h) | sc-410036-NIC | h | Gene Knockout | Puromycin | 0 | ||
LANCL2 Double Nickaseプラスミド (h2) | sc-410036-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
LANCL2 CRISPR/Cas9 KOプラスミド (m) | sc-428092 | m | Gene Knockout | GFP | 0 | ||
LANCL2 HDRプラスミド (m) | sc-428092-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
LANCL2 Double Nickaseプラスミド (m) | sc-428092-NIC | m | Gene Knockout | Puromycin | 0 | ||
LANCL2 Double Nickaseプラスミド (m2) | sc-428092-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
LANCL3 CRISPR/Cas9 KOプラスミド (h) | sc-415629 | h | Gene Knockout | GFP | 0 | ||
LANCL3 HDRプラスミド (h) | sc-415629-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
LANCL3 Double Nickaseプラスミド (h) | sc-415629-NIC | h | Gene Knockout | Puromycin | 0 | ||
LANCL3 Double Nickaseプラスミド (h2) | sc-415629-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
LANCL3 CRISPR/Cas9 KOプラスミド (m) | sc-433500 | m | Gene Knockout | GFP | 0 | ||
LANCL3 HDRプラスミド (m) | sc-433500-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
LANCL3 Double Nickaseプラスミド (m) | sc-433500-NIC | m | Gene Knockout | Puromycin | 0 | ||
LANCL3 Double Nickaseプラスミド (m2) | sc-433500-NIC-2 | m | Gene Knockout | Puromycin | 0 |
LANCL CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
LANCL1 CRISPR Activationプラスミド (h) | sc-409776-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL1 CRISPR Activationプラスミド (h2) | sc-409776-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL1 Lentiviral Activation Particles (h) | sc-409776-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL1 Lentiviral Activation Particles (h2) | sc-409776-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL1 CRISPR Activationプラスミド (m) | sc-420659-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL1 CRISPR Activationプラスミド (m2) | sc-420659-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL1 Lentiviral Activation Particles (m) | sc-420659-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL1 Lentiviral Activation Particles (m2) | sc-420659-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL2 CRISPR Activationプラスミド (h) | sc-410036-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL2 CRISPR Activationプラスミド (h2) | sc-410036-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL2 Lentiviral Activation Particles (h) | sc-410036-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL2 Lentiviral Activation Particles (h2) | sc-410036-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL2 CRISPR Activationプラスミド (m) | sc-428092-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL2 CRISPR Activationプラスミド (m2) | sc-428092-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL2 Lentiviral Activation Particles (m) | sc-428092-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL2 Lentiviral Activation Particles (m2) | sc-428092-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL3 CRISPR Activationプラスミド (h) | sc-415629-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL3 CRISPR Activationプラスミド (h2) | sc-415629-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL3 Lentiviral Activation Particles (h) | sc-415629-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL3 Lentiviral Activation Particles (h2) | sc-415629-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL3 CRISPR Activationプラスミド (m) | sc-433500-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL3 CRISPR Activationプラスミド (m2) | sc-433500-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL3 Lentiviral Activation Particles (m) | sc-433500-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LANCL3 Lentiviral Activation Particles (m2) | sc-433500-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |